Search
Add filters:
Use filters to refine the search results.
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| 5-Sep-2013 | Regulation of Hippocampal cGMP Levels as a Candidate to Treat Cognitive Deficits in Huntington's Disease | Saavedra, Ana; Giralt Torroella, Albert; Arumí, Helena; Alberch i Vié, Jordi; Pérez Navarro, Esther |
| 2011 | Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction | Giralt Torroella, Albert; Carreton, Olga; Lao-Peregrin, Cristina; Martín, Eduardo D.; Alberch i Vié, Jordi |
| 31-Oct-2011 | Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity | Xifró i Collsamata, Xavier; Anglada Huguet, Marta; Rué Cabré, Laura; Saavedra, Ana; Pérez Navarro, Esther; Alberch i Vié, Jordi |
| 2-Sep-2014 | Neurotrophin receptor p75NTR mediates Huntington's disease-associated synaptic and memory dysfunction | Brito, Verónica; Giralt Torroella, Albert; Enriquez-Barreto, Lilian; Puigdellívol Cañadell, Maria del Mar; Suelves Caballol, Núria; Zamora-Moratalla, Alfonsa; Ballesteros, Jesús J.; Martín, Eduardo D.; Dominguez-Iturza, Nuria; Morales, Miguel; Alberch i Vié, Jordi; Ginés Padrós, Silvia |
| 30-Jun-2010 | A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing | Martí Puig, Eulàlia; Pantano, Lorena; Bañez-Coronel, Mónica; Llorens Torres, Franc; Miñones Moyano, Elena; Porta, Sílvia; Sumoy, Lauro; Ferrer, Isidro (Ferrer Abizanda); Estivill, Xavier, 1955- |
| 1-Nov-2016 | Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels | Rué Cabré, Laura; Bañez-Coronel, Mónica; Creus Muncunill, Jordi; Giralt Torroella, Albert; Alcalá Vida, Rafael; Mentxaka, Gartze; Kagerbauer, Birgit; Zomeño Abellán, M. Teresa; Aranda, Zeus; Venturi, Verónica; Pérez Navarro, Esther; Estivill, Xavier, 1955-; Martí Puig, Eulàlia |
| 30-May-2017 | Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington's disease model. | Giralt Torroella, Albert; Brito, Verónica; Chevy, Quentin; Simonnet, Clémence; Otsu, Yo; Cifuentes Díaz, Carmen; Pins, Benoit de; Coura, Renata; Alberch i Vié, Jordi; Ginés Padrós, Silvia; Poncer, Jean Christophe; Girault, Jean-Antoine |
| 1-Jun-2011 | Striatal-Enriched Protein Tyrosine Phosphatase Expression and Activity in Huntington's Disease: A STEP in the Resistance to Excitotoxicity | Saavedra, Ana; Giralt Torroella, Albert; Rué Cabré, Laura; Xifró i Collsamata, Xavier; Xu, Jian; Ortega, Zaira; Lucas, José J.; Lombroso, Paul J.; Alberch i Vié, Jordi; Pérez Navarro, Esther |
| 1-Sep-2015 | Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease | Fernández-Nogales, Marta; Hernández, Félix; Miguez, Andrés; Alberch i Vié, Jordi; Ginés Padrós, Silvia; Pérez Navarro, Esther; Lucas, José J. |
| 20-Mar-2017 | Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice | Pardo Muñoz, Mònica; García Díaz-Barriga, Gerardo A.; Straccia, Marco; Sanders, Phil; Alberch i Vié, Jordi; Canals i Coll, Josep M.; HD iPSC Consortium |
Discover
Subject